Pharmacological stimulation of group II metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 922-931

  Adewale, A S ^a,b   Platt, D M ^a   Spealman, R D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Organon USA Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; COCAINE; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; INSTRUMENTAL CONDITIONING; MALE; MOTOR COORDINATION; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; SQUIRREL MONKEY; VISUAL STIMULATION; VOMITING;

AMINO ACIDS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; FEMALE; MALE; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE, SKELETAL; PSYCHOMOTOR PERFORMANCE; RECEPTORS, METABOTROPIC GLUTAMATE; RECURRENCE; SAIMIRI; SELF ADMINISTRATION; STIMULATION, CHEMICAL; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33745966819     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105387     Document Type: Article

References (39)

1. Backstrom P and Hyytia P (2005) Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG. Eur J Pharmacol 528:110-118.
2. Baptista MA, Martin-Fardon R, and Weiss F (2004) Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J Neurosci 24:4723-4727.
3. Baptista MA, Martin-Fardon R, and Weiss F (2005) Effects of LY379268, an -mGluR2/3 agonist, on cocaine self-administration and cocaine prime-induced cocaine seeking behavior in cocaine-escalated versus nonescalated rats (on-line). Soc Neurosci Abstr, Program 561.3, Society for Neuroscience, Washington, DC.
4. Bond A, Jones NM, Hicks CA, Whiffin GM, Ward MA, O'Neill MF, Kingston AE, Monn JA, Ornstein PL, Schoepp DD, et al. (2000) Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo. J Pharmacol Exp Ther 294:800-809.
5. Bossert JM, Busch RF, and Gray SM (2005) The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 16:1013-1016.
6. Cartmell J, Monn JA, and Schoepp DD (2000) The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing. Eur J Pharmacol 400:221-224.
7. Cartmell J and Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889-907.
8. Conn PJ and Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:203-237.
9. Cornish JL and Kalivas PW (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20:1-5.
10. Di Ciano P and Everitt BJ (2001) Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25:341-360.
11. Everitt BJ and Robbins TW (2000) Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behavior. Psychopharmacology 153:17-30.
12. Feinberg I, Campbell IG, Schoepp DD, and Anderson K (2002) The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat. Pharmacol Biochem Behav 73:467-474.
13. Feinberg I, Schoepp DD, Hsieh KC, Darchia N, and Campbell IG (2005) The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist LY379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4, 6-dicarboxylate] in rats. J Pharmacol Exp Ther 312:826-833.
14. Goldberg SR, Kelleher RT, and Goldberg DM (1981) Fixed-ratio responding under second-order schedules of food presentation or cocaine injection. J Pharmacol Exp Ther 218:271-281.
15. Goldberg SR, Spealman RD, and Kelleher RT (1979) Enhancement of drug-seeking behavior by environmental stimuli associated with cocaine or morphine injections. Neuropharmacology 18:1015-1017.
16. Hu G, Duffy P, Swanson C, Ghasemzadeh MB, and Kalivas PW (1999) The regulation of dopamine transmission by metabotropic glutamate receptors. J Pharmacol Exp Ther 289:412-446.
17. Kalivas PW (2004) Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4:23-29.
18. Kenny PJ and Markou A (2004) The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol Sci 25:265-272.
19. Kim JH, Austin JD, Tanabe L, Creekmore E, and Vezina P (2005) Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Eur J Neurosci 21:295-300.
20. Kim JH and Vezina P (2002) The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Pharmacol Biochem Behav 73:333-337.
21. Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S, and Schoepp DD (1998) LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37:1-12.
22. Lee B, Platt DM, Rowlett JK, Adewale AS, and Spealman RD (2005) Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharmacol Exp Ther 312:1232-1240.
23. Li Y, Vartanian AJ, White FJ, Xue CJ, and Wolf ME (1997) Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology 134:266-276.
24. Monn JA, Valli MJ, Massey SM, Hansen MM, Kress TJ, Wepsiec JP, Harkness AR, Grutsch JL Jr, Wright RA, Johnson BG, et al. (1999) Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 42:1027-1040.
25. Moran MM, McFarland K, Melendez RI, Kalivas PW, and Seamans JK (2005) Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci 25:6389-6393.
26. Morishima Y, Miyakawa T, Furuyashiki T, Tanaka Y, Mizuma H, and Nakanishi S (2005) Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. Proc Natl Acad Sci USA 102:4170-4175.
27. Pierce RC, Bell K, Duffy P, and Kalivas PW (1996) Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1560.
28. Pierce RC, Meil WM, and Kalivas PW (1997) The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology 133:188-195.
29. Platt DM, Carey G, and Spealman RD (2005) Intravenous self-administration techniques in monkeys, in Current Protocols in Neuroscience (Crawley J, Gerfen C, Rogawski M, Sibley D, Skolnick P, and Wray S eds) pp 9.21.1-9.21.15, John Wiley, Hobokun, NJ.
30. Platt DM, Rowlett JK, and Spealman RD (2000) Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J Pharmacol Exp Ther 293:1017-1026.
31. Schoepp DD (2001) Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12-20.
32. Spealman RD, Bergman J, Madras BK, and Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258:945-953.
33. Spealman RD and Goldberg SR (1978) Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol 18:313-339.
34. Spealman RD, Lee B, Tiefenbacher S, Platt DM, Rowlett JK, and Khroyan TV (2004) Triggers of relapse: nonhuman primate models of reinstated cocaine seeking. Nebr Symp Motiv 50:57-84.
35. Tzschentke TM and Schmidt WJ (2003) Glutamatergic mechanisms in addiction. Mol Psychiatry 8:373-382.
36. Weiss F (2005) Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol 5:9-19.
37. Winslow JT, Newman JD, and Insel TR (1989) CRH and alpha-helical-CRH modulate behavioral measures of arousal in monkeys. Pharmacol Biochem Behav 32:919-926.
38. Xi ZX, Baker DA, Shen H, Carson DS, and Kalivas PW (2002a) Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens. J Pharmacol Exp Ther 300:162-171.
39. Xi ZX, Ramamoorthy S, Baker DA, Shen H, Samuvel DJ, and Kalivas PW (2002b) Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine. J Pharmacol Exp Ther 303:608-615.